Mahindra & Mahindra approves ₹1,450 crore investment in SML Mahindra rights issue
Mahindra & Mahindra · Automobiles
Key highlights
- M&M approved subscription to SML's rights issue on 6th Nov 2026, totaling up to ₹1,450 crore
- Initial subscription of ~₹855 crore for full rights entitlement and up to ~₹595 crore for unsubscribed shares
- SML Mahindra Limited, incorporated 26 July 1983, reported turnover of ₹2,837.92 crore in FY 2025-26 and operates mainly in India with exports to several countries
Why it's rated notable: amount is ₹500 crore or more
Original filing
Announcement under Regulation 30 (LODR)-Acquisition
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other fundraise / allotment filings this fortnight
- Supreme Engineering allots 14,50,00,000 warrants at ₹2.60 on preferential basis
- Bajaj Finance Limited allots 5.74 crore warrants to Bajaj Finserv on 10 Nov 2026
- Bajaj Finance approves preferential issue of 5.74 crore warrants to Bajaj Finserv
- Chaman Metallics Limited announces H1 FY27 financial results and proposed Rights Issue
- Harmony Capital Services receives BSE approval for preferential issue of shares
- Kuber Udyog: open offer corrigendum, allotments of shares and warrants at ₹23.10
Potential multibaggers · Q2 FY27
Potential multibaggers in Automobiles
on management's own guidance
- 2
- Strong growth1
- Bajaj AutoGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.